{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:14:02Z","timestamp":1761178442008,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.canrad.2013.11.010","type":"journal-article","created":{"date-parts":[[2014,1,24]],"date-time":"2014-01-24T12:45:24Z","timestamp":1390567524000},"page":"83-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chimioradioth\u00e9rapie de rattrapage \u00e0 vis\u00e9e curative de rechutes pelviennes isol\u00e9es de cancers du col ut\u00e9rin"],"prefix":"10.1016","volume":"18","author":[{"given":"N.","family":"Besson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Touboul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9.","family":"Dara\u00ef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-P.","family":"Lefranc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Monnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Schlienger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2013.11.010_bib0005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.respe.2008.03.117","article-title":"Cancer incidence and mortality in France over the period 1980\u20132005","volume":"56","author":"Belot","year":"2008","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.canrad.2013.11.010_bib0010","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0360-3016(02)02971-1","article-title":"Operable stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy","volume":"54","author":"Atlan","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.11.010_bib0015","first-page":"S43","article-title":"Carcinoma of the cervix uteri. FIGO 26th Annual report on the results of treatment in gynecological cancer","volume":"95","author":"Quinn","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.canrad.2013.11.010_bib0020","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1200\/JCO.2008.16.4368","article-title":"Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18\u00a0randomized trials","volume":"26","author":"Chemotherapy for Cervical Cancer Meta-Analysis Collaboration","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2013.11.010_bib0025","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.ijrobp.2008.03.054","article-title":"Preoperative concurrent radiation therapy and chemotherapy for bulky stage IIB2, IIA and IIB carcinoma of the uterine cervix with proximal parametrial invasion","volume":"72","author":"Huguet","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.11.010_bib0030","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.ijrobp.2006.11.013","article-title":"Long-term outcome after radiotherapy for FIGO stage IIIB and IVA carcinoma of the cervix","volume":"67","author":"Yeung","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.11.010_bib0035","first-page":"782","article-title":"R\u00e9cidives locor\u00e9gionales des cancers du col ut\u00e9rin et du corps ut\u00e9rin\u00a0: place de la chirurgie","volume":"92","author":"Houvenaeghel","year":"2005","journal-title":"Bull Cancer"},{"key":"10.1016\/j.canrad.2013.11.010_bib0040","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0090-8258(88)90252-1","article-title":"recurrent cervical carcinoma after radical hysterectomy","volume":"30","author":"Larson","year":"1988","journal-title":"Gyneco Oncol"},{"key":"10.1016\/j.canrad.2013.11.010_bib0045","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/0090-8258(90)90311-8","article-title":"Optimal therapy for pelvic recurrence after radical hysterectomy for early-stage cervical cancer","volume":"37","author":"Potter","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2013.11.010_bib0050","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1006\/gyno.1997.4855","article-title":"Radiotherapy for centrally recurrent cervical cancer of the vaginal stump following hysterectomy","volume":"67","author":"Ito","year":"1997","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2013.11.010_bib0055","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/gyno.1998.5093","article-title":"Radiation therapy of pelvic recurrence after radical hysterectomy for cervical carcinoma","volume":"70","author":"Ijaz","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2013.11.010_bib0060","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0002-9378(99)70486-2","article-title":"Recurrent cervical carcinoma after primary radical surgery","volume":"181","author":"Wang","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.canrad.2013.11.010_bib0065","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s00066-003-1100-6","article-title":"Therapeutic outcome and prognostic factors in the radiotherapy of recurrences of cervical carcinoma following surgery","volume":"179","author":"Hille","year":"2003","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.canrad.2013.11.010_bib0070","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/ijgc-00009577-200409000-00018","article-title":"Prospective phase I\/II study of irradiation and concurrent chemotherapy for recurrent cervical cancer after radical hysterectomy for carcinoma of the cervix recurrent after surgery","volume":"14","author":"Grigsby","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.canrad.2013.11.010_bib0075","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.radonc.2008.01.004","article-title":"Long-term results of salvage radiotherapy for the treatment of recurrent cervical carcinoma after prior surgery","volume":"89","author":"Haasbeek","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2013.11.010_bib0080","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.ijrobp.2004.12.029","article-title":"Intensity-modulated radiation therapy after hysterectomy: comparison with conventionnal treatment and sensitivy of the normal-tissue-sparing effect to margin size","volume":"62","author":"Ahamad","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.11.010_bib0085","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.ijrobp.2006.11.005","article-title":"Clinical outcome in posthysterectomy cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy: comparison with conventional radiotherapy","volume":"67","author":"Chen","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.11.010_bib0090","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ijrobp.2011.12.020","article-title":"Postoperative intensity-modulated arc therapy for cervical and endometrial cancer. A prospective report on toxicity","volume":"84","author":"Vandecasteele","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.11.010_bib0095","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2013.01.017","article-title":"Hematologic toxicity in RTOG0418: a phase 2\u00a0study of postoperative IMRT for gynecologic cancer","volume":"86","author":"Klopp","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.11.010_bib0100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijrobp.2004.02.044","article-title":"Recurrent squamous cell carcinoma of cervix after definitive radiotherapy","volume":"60","author":"Hong","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2013.11.010_bib0105","first-page":"1027","article-title":"Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix","volume":"73","author":"Shingleton","year":"1989","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.canrad.2013.11.010_bib0110","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/ijgc-00009577-200409000-00016","article-title":"Surgical resection of locally recurrent cervical cancer: a single institutional 70\u00a0patients series","volume":"14","author":"Moutardier","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.canrad.2013.11.010_bib0115","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0090-8258(03)00502-X","article-title":"Laterally extended endopelvic resection. Novel surgical treatment of locally recurrent cervical carcinoma involving the pelvic side","volume":"91","author":"H\u00f6ckel","year":"2003","journal-title":"Gyn Oncol"},{"key":"10.1016\/j.canrad.2013.11.010_bib0120","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1200\/JCO.2009.21.8909","article-title":"Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent or persistent cervical carcinoma: a Gynecologic Oncology Group study","volume":"27","author":"Monk","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2013.11.010_bib0125","first-page":"263","article-title":"Traitement m\u00e9dical des cancers du col ut\u00e9rin m\u00e9tastatiques et r\u00e9cidivants","volume":"93","author":"de la Motte-Rouge","year":"2006","journal-title":"Bull Cancer"},{"key":"10.1016\/j.canrad.2013.11.010_bib0130","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/SLA.0b013e318242ebe7","article-title":"Hyperthermic pelvic perfusion with tumors necrosis factor-alpha for locally advanced cancers: encouraging results of a phase II study","volume":"255","author":"Bonvalot","year":"2012","journal-title":"Ann Surg"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321813004472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321813004472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:22:12Z","timestamp":1761135732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321813004472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1278321813004472"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2013.11.010","relation":{},"ISSN":["1278-3218"],"issn-type":[{"type":"print","value":"1278-3218"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chimioradioth\u00e9rapie de rattrapage \u00e0 vis\u00e9e curative de rechutes pelviennes isol\u00e9es de cancers du col ut\u00e9rin","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2013.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}